Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González

La formación de médicos especialistas dermatólogos con un alto grado de competencia y eficiencia a nivel internacional, con bases científicas, asistenciales, de investigación, éticas y humanísticas apropiadas para brindar una atención de excelencia, asegurando el desarrollo profesional y liderazgo en la comunidad donde labore y que contribuya a mejorar su nivel de salud. Así como contribuir con la industria farmacéutica en el desarrollo de nuevas moléculas o ya existentes para distintas indicaciones médicas dermatológicas, mediante la ejecución de estudios de ensayos clínicos de manera ética y bajo la regulación y normatividad nacional.

Av. Madero y Gonzalitos S/N, Mitras Centro, Monterrey, Nuevo León

Websitehttp://www.medicina.uanl.mx/hu/

Select an option

I am a doctor

I am a sponsor

Specializations

Psoriasis pustulosa generalizada

Diabetes

Covid-19

Coronavirus

Carcinoma hepatocelular

Enfermedad de Alzheimer

Fibrosis pulmonar

Leucemia

Nefritis lúpica

Our team

Medical staff

Jorge de Jesús Ocampo Candiani

Uriel Chavarría Martínez

Diana Flores Alvarado

Perla Martinez Leyva

Sonia Chávez Álvarez

Minerva Gómez Flores

C. Lucio Vera Cabrera

Osvaldo Vazquez Martinez

Maira Elizabeth Herz Ruelas

Carmen Molina Torres

Alejandra Villarreal Martínez

Fania Zamantta Muñoz Fuentes

Erika Lizbeth Alba Rojas

Adrián Cuellar Barboza

Gabriela Zapata González

Maria Elena Deveze Villarreal

Myrthala Juarez

Elizabeth Arias Reyes

Erasmo Saucedo Uribe

Javier Garza

Adrián Rendón

Brenda Nohemi Lozano

Berenice Soto

Perla R Colunga Pedraza

Open studies

Breast Cancer

A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) - heredERA - Hoffmann-La Roche

Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies - Palbociclib - Pfizer

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - Pfizer

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer - INAVO122 - Hoffmann-La Roche

Arthritis

A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis - JUVE-X - Eli Lilly and Company

A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) - I4V-MC-JAHU - Eli Lilly and Company

Lung cancer

A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases - MO41552 - Hoffmann-La Roche

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - Pfizer

Lupus

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus - TOPAZ-1 - Biogen

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - POETYK SLE-2 - Bristol-Myers Squibb

Pulmonary fibrosis

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis - ALOFT-IPF - Bristol-Myers Squibb

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis - ALOFT-PPF - Bristol-Myers Squibb

Colorectal cancer

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - Pfizer

Dental and oral disorders

Periodontal Regeneration With Recombinant Human Platelet Derived Growth Factor (rH-PDGF-BB) and Allograft - Lynch Biologics LLC

Head and neck cancer

Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies - Palbociclib - Pfizer

Leukemia

Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia - Dasatinib - Fernando De la Garza Salazar

Liposarcoma

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - Pfizer

Lymphoma

Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkin's Lymphoma - HE23-0001 - Hospital Universitario Dr. Jose E. Gonzalez

Ocular Graft versus Host Disease

Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT - Hospital Universitario Dr. Jose E. Gonzalez

Prostate cancer

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - Pfizer

Schizophrenia

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) - CONNEX-1 CONNEX-2 CONNEX-3 - Boehringer Ingelheim

Solid tumors

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - Pfizer

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads

Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González

Av. Madero y Gonzalitos S/N, Mitras Centro, Monterrey, Nuevo León

Websitehttp://www.medicina.uanl.mx/hu/

Select an option

I am a doctor

I am a sponsor

Specializations

Psoriasis pustulosa generalizada

Diabetes

Covid-19

Coronavirus

Carcinoma hepatocelular

Enfermedad de Alzheimer

Fibrosis pulmonar

Leucemia

Nefritis lúpica

Our team

Medical staff

Jorge de Jesús Ocampo Candiani

Uriel Chavarría Martínez

Diana Flores Alvarado

Perla Martinez Leyva

Sonia Chávez Álvarez

Minerva Gómez Flores

C. Lucio Vera Cabrera

Osvaldo Vazquez Martinez

Maira Elizabeth Herz Ruelas

Carmen Molina Torres

Alejandra Villarreal Martínez

Fania Zamantta Muñoz Fuentes

Erika Lizbeth Alba Rojas

Adrián Cuellar Barboza

Gabriela Zapata González

Maria Elena Deveze Villarreal

Myrthala Juarez

Elizabeth Arias Reyes

Erasmo Saucedo Uribe

Javier Garza

Adrián Rendón

Brenda Nohemi Lozano

Berenice Soto

Perla R Colunga Pedraza

Open studies

Breast Cancer

Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies - Palbociclib - Pfizer

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - Pfizer

Arthritis

A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis - JUVE-X - Eli Lilly and Company

A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) - I4V-MC-JAHU - Eli Lilly and Company

Lung cancer

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - Pfizer

Lupus

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus - TOPAZ-1 - Biogen

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - POETYK SLE-2 - Bristol-Myers Squibb

Pulmonary fibrosis

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis - ALOFT-IPF - Bristol-Myers Squibb

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis - ALOFT-PPF - Bristol-Myers Squibb

Colorectal cancer

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - Pfizer

Dental and oral disorders

Periodontal Regeneration With Recombinant Human Platelet Derived Growth Factor (rH-PDGF-BB) and Allograft - Lynch Biologics LLC

Head and neck cancer

Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies - Palbociclib - Pfizer

Leukemia

Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia - Dasatinib - Fernando De la Garza Salazar

Liposarcoma

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - Pfizer

Lymphoma

Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkin's Lymphoma - HE23-0001 - Hospital Universitario Dr. Jose E. Gonzalez

Ocular Graft versus Host Disease

Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT - Hospital Universitario Dr. Jose E. Gonzalez

Prostate cancer

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - Pfizer

Schizophrenia

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) - CONNEX-1 CONNEX-2 CONNEX-3 - Boehringer Ingelheim

Solid tumors

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - Pfizer

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads